coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Walkden & Little Hulton PCN, Salford (LAD) · Health Inequalities Profile

    PCN U69393 · NHS Greater Manchester Integrated Care Board · 9 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    45,577

    Registered population

    60.6% aged 18–64

    16.2%

    Aged 65+

    ICB 14.9% · England 17.9%

    42.5%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~16,999

    Core20 residents (est.)

    Resident basis; registered basis ~20,039 · see page 3

    7,168

    Hypertension register

    +5.37% in 3 yrs · England +5.60%

    424

    SMI register

    11.4% of Salford (LAD)'s

    1,248

    COPD register

    Reviews +0.79% in 3 yrs

    Forecast to 2030

    8,324

    Hypertension patients, 2030

    +1,156 on today

    70.1%

    QRISK ≥20% on statins, 2030

    +1.86pp over 3 yrs

    4.4%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    10
    Ten three-year clinical trends trail England.

    Over 2023 to 2025, 10 of 25 measures trail England, including learning disability prevalence (-2.6% versus +5.4%) and diabetes statins (-1.4% versus +2.1%).

    637
    Scale indicator of unreviewed asthma patients.

    Asthma review coverage is 78.7% across 2,987 registered patients, leaving a scale indicator of 637 unreviewed patients that may reflect unverified recall gaps.

    80.8%
    Hypertension and diabetes control exceed England.

    Hypertension treated to target reaches 80.8% (England 70.3%) and diabetes HbA1c control without frailty reaches 65.2% (England 57.4%) for registered patients.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Across 45,577 patients, 23.2% are children, exceeding the England rate of 19.6%

    Across 45,577 registered patients, 23.2% (10,565) are aged 0-17, above Salford (LAD) at 21.4%, NHS Greater Manchester Integrated Care Board at 21.8%, and England at 19.6%. Those aged 65+ comprise 16.2% (7,379 patients), versus 14.4% in Salford (LAD), 14.9% in the ICB, and 17.9% in England. Gypsy or Irish Traveller and Roma groups each record 0.1%. Unadjusted dementia prevalence of 0.5% (236 patients) sits below Salford (LAD) at 0.6%, NHS Greater Manchester Integrated Care Board at 0.7%, and England at 0.8%, which may reflect age structure.

    Age profile

    0–1723.2%
    18–6460.6%
    65+16.2%

    65+: ICB 14.9%, England 17.9%

    Older people · falls rows are Salford (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Salford LA)2,9802,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)91.8%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)65.2%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Salford LA)1,5101,0219552024/25
    Falls deaths, all ages, per 100,000 (Salford LA)15.718.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 42.5% across the PCN and varies 100 pp across practices

    Registered patients in the Core20 cohort make up 42.5% of the PCN, below Salford (LAD) at 44.0%, but above NHS Greater Manchester Integrated Care Board (40.7%) and England (21.0%). The weighted practice share of 44.0% exceeds the PCN rate by 1.50 percentage points. Practice concentration spans 100 pp, from 0.0% at Ellenbrook Medical Centre and Orchard Medical Practice to 100.0% at Dearden Avenue Medical Practice, while Cleggs Lane Medical Practice/129 holds 4,926 estimated Core20 patients. Resource allocation should address high concentration alongside absolute volume.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Dearden Avenue100.0% · 2,759 patients
    Cherry Medical95.7% · 3,144 patients
    Cleggs Lane95.3% · 4,926 patients
    Manchester Road88.7% · 2,017 patients
    Gill Medical37.5% · 3,721 patients
    Walkden27.4% · 2,427 patients
    Limes Medical21.9% · 1,045 patients
    Ellenbrook0.0% · 0 patients
    Orchard Medical0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    424

    SMI register

    0.94% recorded prevalence

    272

    Learning disability register

    0.60% recorded prevalence

    7

    Care homes, 276 beds

    In the PCN catchment

    9.2%

    Provide unpaid care

    Salford (LAD), Census 2021

    The severe mental illness register records 424 patients (0.9%), below Salford (LAD) (1.1%), the ICB (1.1%) and England (1.0%). The learning disability register records 272 patients (0.6%), above Salford (LAD) (0.5%) and matching the ICB (0.6%) and England (0.6%). Care home catchment includes 7 homes with 276 beds.

    Severe mental illness: physical health checks

    Severe mental illness recorded prevalence is 0.9% (424 patients). Blood pressure checks reach 91.1% (England 83.4%) and BMI checks reach 91.4% (England 82.1%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    7,168

    Hypertension register

    +5.37%

    Register growth, 3 yrs

    Salford (LAD) +5.45% · England +5.60%

    +5.50pp

    BP control, under 80

    ≤140/90 · +1.99pp aged 80+

    +1,156

    More patients by 2030

    Forecast 8,324 (17.69%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 15.9% (7,168 patients), above Salford (LAD) (12.4%), NHS Greater Manchester Integrated Care Board (14.4%), and England (15.2%). Blood pressure treated to target is 80.8%, exceeding Salford (LAD) (77.6%), the ICB (71.4%), and England (70.3%). Recent blood pressure reading coverage is 94.4% (England 90.0%), though three-year reading growth of +3.2% trails England (+3.6%) and Salford (LAD) (+4.6%). Across practices, recorded prevalence spans from 12.2% at Dearden Avenue Medical Practice and 12.4% at Cleggs Lane Medical Practice/129 to 18.4% at The Gill Medical Practice. Trailing three-year reading growth could reflect established baseline coverage; audits across lower-prevalence practices may help test local recording.

    Lipids and statins

    Lipid therapy reach is 66.2% for QRISK ≥ 20% (England 63.6%) and 78.5% in diabetes without CVD (England 73.2%). Over 2023 to 2025, treatment changes trailed England in diabetes (-1.4% versus +2.1%) and QRISK ≥ 20% (+2.9% versus +6.2%).

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202694,483£1.60£1.94£1.86£151,173
    Cardiovascular (all), 2025129,930£2.44£3.15£3.33£317,029

    In 2026, the PCN prescribed 94,483 lipid-regulating drug items at £1.60 per item, compared with £1.54 in Salford (LAD), £1.94 in NHS Greater Manchester Integrated Care Board, and £1.86 in England. Across these 94,483 items, the PCN spent £24,566 less than at England's unit cost.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +10.75%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −2.20%

    Asthma prevalence, PCN 3-yr % change

    Recorded COPD prevalence is 2.8% (1,248 patients; England 1.9%), with reviews at 84.0% (England 76.4%), though 2023 to 2025 review change of +0.8% trailed Salford (LAD) (+12.2%). Asthma prevalence is 7.2% (2,987 patients; England 6.6%), where 78.7% had an annual review (England 65.7%). This leaves an unreviewed scale indicator of 637 patients (about 640). Asthma prescribing for ages 5-19 is 1,752 items per 1,000 (England 1,488).

    Cancer register and children's immunisation

    Cancer QOF prevalence is 3.7% (1,670 patients; England 3.8%). Childhood immunisations reach the 95.0% coverage target for 6-in-1 at 12 months (95.8%) and MMR dose 1 at age 5 (95.5%). MMR dose 2 coverage at age 5 is 90.3% (a 5.2 pp difference from dose 1), while 4-in-1 pre-school booster coverage at age 5 is 86.4%, sitting 8.6 pp below the 95.0% coverage target.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months95.8%

    England 91.0%

    6-in-1 complete primary course at 24 months92.1%

    England 92.2%

    MMR dose 1 at 24 months88.1%

    England 88.3%

    MMR dose 2 at age 590.3%

    England 82.8%

    4-in-1 pre-school booster at age 586.4%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    Across NHS Greater Manchester ICB in 2022, 55.6% of cancers with a known stage (6,491 of 11,679) were diagnosed at stage 1 or 2 (England 55.3%), with a distance to the 75.0% national ambition by 2028 of -19.4 pp. Known-stage cancers represented 70.8% of all 16,492 registrations (England 67.0%). The ICB early-stage share rose +3.1 pp from 52.4% in 2013, leaving an estimated gap of about 2,270 additional early diagnoses annually across the system to achieve the ambition. These figures describe wider ICB staging rather than PCN performance. Primary care contribution centres on prompt referral and screening uptake to support earlier presentation across system pathways.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    At Northern Care Alliance NHS Foundation Trust, the distance to the 85.0% 62-day cancer referral to treatment standard is -6.4 pp, the distance to the 75.0% 28-day faster diagnosis standard is 0.2 pp, and the distance to the 96.0% 31-day combined treatment standard is -1.5 pp. Across NHS Greater Manchester Integrated Care Board, the distance to the 62-day standard is -9.3 pp, the distance to the 28-day standard is 4.5 pp, and the distance to the 31-day standard is 0.5 pp. These figures describe acute trust and ICB performance rather than PCN delivery.

    Pathways within standard (%)Northern Care AllianceBoltonManchesterGreater Manchester ICBEngland
    28-day faster diagnosis (75%)75.2080.4880.0679.5379.32
    31-day treatment (96%)94.5496.5092.5496.4992.50
    62-day referral to treatment (85%)78.6569.6672.8575.7371.16
    Diagnostic waits over 6 weeks (%)Northern Care AllianceBoltonManchesterEngland
    MRI5.092.0511.6821.40
    CT4.1019.4014.669.92
    Echocardiography31.483.484.9128.48
    Colonoscopy40.041.334.5130.83
    Gastroscopy36.482.0629.3529.02
    All 15 DM01 tests15.7115.788.9823.14
    Community services activitySalford residentsGreater Manchester ICB
    Care contacts37,955573,310
    Referrals3,34094,470
    Patients with a contact15,440183,535

    Community services (residents of Salford), Jun 2026 (provisional). In the Community Services Dataset (Jun 2026 (provisional)), adults aged 65 and over accounted for 53.9% of all contacts among Salford residents (20,470 of 37,955 contacts). These borough-level figures demonstrate substantial older-age community caseload demand, though activity was not captured at PCN level.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    In 2025/26, England clinical-domain achievement was 97.1%. QOF clinical achievement reached 96.8% at Ellenbrook Medical Centre and 100.0% at The Gill Medical Practice. In the vaccination and immunisation domain, achievement ranged 55.3 pp, from 15.6% at Dearden Avenue Medical Practice and The Limes Medical Practice to 70.9% at Cleggs Lane Medical Practice/129.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Gill Medical12837.581.0%79.9%88.1%
    Cherry Medical8695.791.1%81.9%86.3%
    Ellenbrook1430.062.1%71.2%85.2%
    Cleggs Lane12395.373.5%75.6%84.5%
    Dearden Avenue105100.077.8%72.4%83.7%
    Manchester Road10088.791.0%77.3%83.3%
    Limes Medical11221.972.2%81.9%81.8%
    Orchard Medical1060.088.5%80.0%79.4%
    Walkden14227.464.9%72.8%63.4%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNSalford (LAD)AssetPCNSalford (LAD)
    Care homes (catchment)7 (276 beds)n/aSchools (catchment)45n/a
    Children's centres416Places of worship19118
    Libraries316Primary schools (LA maintained)1552
    Primary academies421

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Audit trailing register and statin trends

    Over 2023 to 2025, 10 of 25 measures trail England, including learning disability prevalence (-2.6% versus +5.4%) and statins in diabetes without CVD (-1.4% versus +2.1%). For discussion: practices could audit learning disability register coding and run recall searches for high-risk lipid and heart failure reviews. Moderate effort to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Option 2

    Structured recall for unreviewed asthma patients

    Asthma annual review coverage is 78.7% (England 65.7%; Salford (LAD) 71.6%) across 2,987 registered patients, leaving a scale indicator of 637 unreviewed patients. For discussion: the PCN could run structured asthma review recalls using a single template and flexible after-school or holiday slots. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Dementia coding and case-finding review

    Recorded dementia prevalence is 0.5% (236 patients) versus 0.6% in Salford (LAD) and 0.8% in England, giving an unadjusted gap range of +47 to +121 patients. For discussion: practices could audit cognitive assessment coding and check care-home records to verify whether patients with diagnoses are coded. Low cost, quick to run.

    Evidence base: dementia diagnosis rates lag in deprived and minority ethnic populations and in care homes; the register is the cohort for diagnosis-rate improvement and the annual dementia review, and diagnosis and post-diagnostic support delay care-home entry.

    Policy anchor: national dementia diagnosis-rate ambition of 66.7%; 95% of people with complex needs to have an agreed care plan by 2027.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Dementia case finding audit (p2)Registered population · Aged 0-17Neighbourhood health framework · Medium Term Planning Framework 2026PCN
    Two-track Core20 outreach model (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Sustain SMI health check delivery (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension recall review (p5)Hypertension patients with a recent blood pressure readingCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall catch-up (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Early diagnosis pathway audit (p7)Cancers diagnosed at stage 1 or 2 (All cancer sites)—ICB
    Option 1 · Audit trailing register and statin trends (p12)Learning disability register · Learning disability: QOF prevalence · Patients with heart failure who had a review in the last 12 months including the assessment of functional capacity (denominator incl. PCAs)75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Option 2 · Structured recall for unreviewed asthma patients (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 3 · Dementia coding and case-finding review (p12)Dementia register · Dementia: QOF prevalence · Aged 65+66.7% diagnosis ambition · 95% care plan 2027PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15